This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
WLKP or PAH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
WLKP vs. PAH: Which Stock Is the Better Value Option?
Why Is Platform Specialty (PAH) Up 7.7% Since Last Earnings Report?
by Zacks Equity Research
Platform Specialty (PAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Platform Specialty Announces New Term Loan B and Revolver
by Zacks Equity Research
Platform Specialty's (PAH) proposed facilities represent a strong step toward establishing a standalone Element Solutions.
Platform Specialty (PAH) Q3 Earnings Meet, Revenues Miss
by Zacks Equity Research
Platform Specialty's (PAH) Performance Solutions businesses achieve organic sales growth in all end markets amid certain challenges in Q3.
Platform Specialty Products (PAH) Q3 Earnings Match Estimates
by Zacks Equity Research
Platform Specialty (PAH) delivered earnings and revenue surprises of 0.00% and -2.69%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings Slated on Nov 1: DWDP, CC, PAH & ICL
by Anindya Barman
Investors should check these chemical stocks before their quarterly results as the industry is expected to sustain the momentum in Q3.
Platform Specialty Products (PAH) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Platform Specialty (PAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Platform Specialty (PAH) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Platform Specialty (PAH) is focused on finalizing its restructuring plans over the remainder of 2018.
Platform Specialty Products (PAH) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Platform Specialty (PAH) delivered earnings and revenue surprises of 8.33% and 3.88%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Q2 Earnings Slated on Aug 2: DWDP, WLK & More
by Anindya Barman
Chemical companies are likely to gain from strategic actions and a favorable demand environment in Q2.
Platform Specialty (PAH) Up 22% in 3 Months: Here's Why
by Zacks Equity Research
Platform Specialty's (PAH) shares ride on forecast-topping earnings performance and upbeat outlook.
Chemical Stock Q1 Earnings Due on May 3: DWDP, WLK, CC & PAH
by Zacks Equity Research
Earnings momentum for the chemical industry is expected to continue in Q1 as the fundamental driving factors remain in place.
Zacks.com featured highlights include: Platform Specialty, Xylem, Cognizant Technology, Huntington Ingalls and Applied Materials
by Zacks Equity Research
Zacks.com featured highlights include: Platform Specialty, Xylem, Cognizant Technology, Huntington Ingalls and Applied Materials
5 Stocks With Robust Sales Growth to Add to Your Portfolio
by Zacks Equity Research
Sustainable improvement in the bottom line comes on the back of solid sales growth.
Top Ranked Momentum Stocks to Buy for March 20th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 20th:
Platform Specialty (PAH) Looks Good: Stock Adds 5.6% in Session
by Zacks Equity Research
Platform Specialty (PAH) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
Factors That Could Mar Chemical Industry Momentum
by Anindya Barman
There are a few reasons to be cautious about the chemical industry in the near term, which we have outlined.
Key Predictions for Q3 Earnings Reports of DWDP, CC, PAH
by Zacks Equity Research
Chemical companies are expected to continue the earnings momentum in Q3 as the fundamental driving factors remained firmly in place.
5 Top-Ranked Stocks with Earnings Beat Potential
by Zacks Equity Research
Bet on five stocks that are likely to outdo earnings estimates.
Zacks.com featured highlights: Papa Murphy's Holdings, Platform Specialty Products, Five9, Best Buy and Sonus Networks
by Zacks Equity Research
Zacks.com featured highlights: Papa Murphy's Holdings, Platform Specialty Products, Five9, Best Buy and Sonus Networks
Is the Options Market Predicting a Spike in Platform Specialty Products (PAH) Stock?
by Zacks Equity Research
Investors in Platform Specialty Products (PAH) need to pay close attention to the stock based on moves in the options market lately.
On the Lookout for Earnings Beat? 5 Top Picks
by Zacks Equity Research
5 top-ranked stocks likely to beat on earnings may offer investors stellar gains.
Why Platform Specialty Products (PAH) Might Surprise This Earnings Season
by Zacks Equity Research
Platform Specialty Products (PAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
AutoZone (AZO) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
AutoZone, Inc. (AZO) is slated to report second-quarter fiscal 2017 (ended Feb 11, 2017) results on Feb 28, before the opening bell.
International Flavors (IFF) Q4 Earnings: Will it Disappoint?
by Zacks Equity Research
International Flavors & Fragrances Inc. (IFF) is scheduled to report fourth-quarter 2016 results on Feb 15, after market close.